Cargando…
Correction: Sartorius et al. “Postprandial Effects of a Proprietary Milk Protein Hydrolysate Containing Bioactive Peptides in Prediabetic Subjects” Nutrients 2019, 11, 1700
Milk proteins have been hypothesized to protect against type 2 diabetes (T2DM) by beneficially modulating glycemic response, predominantly in the postprandial status. This potential is, amongst others, attributed to the high content of whey proteins, which are commonly a product of cheese production...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282018/ https://www.ncbi.nlm.nih.gov/pubmed/32365675 http://dx.doi.org/10.3390/nu12051266 |
_version_ | 1783544047294480384 |
---|---|
author | Sartorius, Tina Weidner, Andrea Dharsono, Tanita Boulier, Audrey Wilhelm, Manfred Schön, Christiane |
author_facet | Sartorius, Tina Weidner, Andrea Dharsono, Tanita Boulier, Audrey Wilhelm, Manfred Schön, Christiane |
author_sort | Sartorius, Tina |
collection | PubMed |
description | Milk proteins have been hypothesized to protect against type 2 diabetes (T2DM) by beneficially modulating glycemic response, predominantly in the postprandial status. This potential is, amongst others, attributed to the high content of whey proteins, which are commonly a product of cheese production. However, native whey has received substantial attention due to its higher leucine content, and its postprandial glycemic effect has not been assessed thus far in prediabetes. In the present study, the impact of a milk protein hydrolysate of native whey origin with alpha-glucosidase inhibiting properties was determined in prediabetics in a randomized, cross-over trial. Subjects received a single dose of placebo or low- or high-dosed milk protein hydrolysate prior to a challenge meal high in carbohydrates. Concentration–time curves of glucose and insulin were assessed. Incremental areas under the curve (iAUC) of glucose as the primary outcome were significantly reduced by low-dosed milk peptides compared to placebo (p = 0.0472), and a minor insulinotropic effect was seen. A longer intervention period with the low-dosed product did not strengthen glucose response but significantly reduced HbA1c values (p = 0.0244). In conclusion, the current milk protein hydrolysate of native whey origin has the potential to modulate postprandial hyperglycemia and hence may contribute in reducing the future risk of developing T2DM. |
format | Online Article Text |
id | pubmed-7282018 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72820182020-06-19 Correction: Sartorius et al. “Postprandial Effects of a Proprietary Milk Protein Hydrolysate Containing Bioactive Peptides in Prediabetic Subjects” Nutrients 2019, 11, 1700 Sartorius, Tina Weidner, Andrea Dharsono, Tanita Boulier, Audrey Wilhelm, Manfred Schön, Christiane Nutrients Correction Milk proteins have been hypothesized to protect against type 2 diabetes (T2DM) by beneficially modulating glycemic response, predominantly in the postprandial status. This potential is, amongst others, attributed to the high content of whey proteins, which are commonly a product of cheese production. However, native whey has received substantial attention due to its higher leucine content, and its postprandial glycemic effect has not been assessed thus far in prediabetes. In the present study, the impact of a milk protein hydrolysate of native whey origin with alpha-glucosidase inhibiting properties was determined in prediabetics in a randomized, cross-over trial. Subjects received a single dose of placebo or low- or high-dosed milk protein hydrolysate prior to a challenge meal high in carbohydrates. Concentration–time curves of glucose and insulin were assessed. Incremental areas under the curve (iAUC) of glucose as the primary outcome were significantly reduced by low-dosed milk peptides compared to placebo (p = 0.0472), and a minor insulinotropic effect was seen. A longer intervention period with the low-dosed product did not strengthen glucose response but significantly reduced HbA1c values (p = 0.0244). In conclusion, the current milk protein hydrolysate of native whey origin has the potential to modulate postprandial hyperglycemia and hence may contribute in reducing the future risk of developing T2DM. MDPI 2020-04-29 /pmc/articles/PMC7282018/ /pubmed/32365675 http://dx.doi.org/10.3390/nu12051266 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Correction Sartorius, Tina Weidner, Andrea Dharsono, Tanita Boulier, Audrey Wilhelm, Manfred Schön, Christiane Correction: Sartorius et al. “Postprandial Effects of a Proprietary Milk Protein Hydrolysate Containing Bioactive Peptides in Prediabetic Subjects” Nutrients 2019, 11, 1700 |
title | Correction: Sartorius et al. “Postprandial Effects of a Proprietary Milk Protein Hydrolysate Containing Bioactive Peptides in Prediabetic Subjects” Nutrients 2019, 11, 1700 |
title_full | Correction: Sartorius et al. “Postprandial Effects of a Proprietary Milk Protein Hydrolysate Containing Bioactive Peptides in Prediabetic Subjects” Nutrients 2019, 11, 1700 |
title_fullStr | Correction: Sartorius et al. “Postprandial Effects of a Proprietary Milk Protein Hydrolysate Containing Bioactive Peptides in Prediabetic Subjects” Nutrients 2019, 11, 1700 |
title_full_unstemmed | Correction: Sartorius et al. “Postprandial Effects of a Proprietary Milk Protein Hydrolysate Containing Bioactive Peptides in Prediabetic Subjects” Nutrients 2019, 11, 1700 |
title_short | Correction: Sartorius et al. “Postprandial Effects of a Proprietary Milk Protein Hydrolysate Containing Bioactive Peptides in Prediabetic Subjects” Nutrients 2019, 11, 1700 |
title_sort | correction: sartorius et al. “postprandial effects of a proprietary milk protein hydrolysate containing bioactive peptides in prediabetic subjects” nutrients 2019, 11, 1700 |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282018/ https://www.ncbi.nlm.nih.gov/pubmed/32365675 http://dx.doi.org/10.3390/nu12051266 |
work_keys_str_mv | AT sartoriustina correctionsartoriusetalpostprandialeffectsofaproprietarymilkproteinhydrolysatecontainingbioactivepeptidesinprediabeticsubjectsnutrients2019111700 AT weidnerandrea correctionsartoriusetalpostprandialeffectsofaproprietarymilkproteinhydrolysatecontainingbioactivepeptidesinprediabeticsubjectsnutrients2019111700 AT dharsonotanita correctionsartoriusetalpostprandialeffectsofaproprietarymilkproteinhydrolysatecontainingbioactivepeptidesinprediabeticsubjectsnutrients2019111700 AT boulieraudrey correctionsartoriusetalpostprandialeffectsofaproprietarymilkproteinhydrolysatecontainingbioactivepeptidesinprediabeticsubjectsnutrients2019111700 AT wilhelmmanfred correctionsartoriusetalpostprandialeffectsofaproprietarymilkproteinhydrolysatecontainingbioactivepeptidesinprediabeticsubjectsnutrients2019111700 AT schonchristiane correctionsartoriusetalpostprandialeffectsofaproprietarymilkproteinhydrolysatecontainingbioactivepeptidesinprediabeticsubjectsnutrients2019111700 |